The Role of Prescription Drug Coverage in Benefits

Sydney Little
Jun 30
9 min read

Prescription drug coverage is the line item that looks like a benefit but functions like a financial risk lever. Most employers treat it as a fixed cost to minimize at renewal. The result is a pharmacy benefit designed around premium savings — not around how employees actually use medications. That gap has a price. It shows up in emergency room visits, hospitalizations, and short-term disability claims that dwarf whatever was saved on the monthly premium. The coverage decision and the cost consequence rarely land in the same budget line, so the connection goes unmanaged.

In This Post

How Drug Coverage Works — and Why the Design Decisions Are Financial Ones
What Are the Key Design Features of Effective Drug Coverage?
The Benefits of Prescription Insurance Depend on Who Needs Drug Coverage — and How the Plan Is Built Around Them
Why the Usual Fix Doesn't Work — and What Actually Does
Strategic Approaches for Employers to Manage Prescription Drug Plans
What Watching Employers Underinvest in Drug Coverage Teaches You
How TBG Helps Employers Manage Prescription Drug Costs

Key Takeaways

Nonadherence Is a Cost Problem	When employees ration medications because of high out-of-pocket costs, employers pay for it in claims — not copays.
Formulary Design Drives Behavior	Tiering, deductible exemptions, and prior authorization rules determine whether employees actually take their medications.
Discount Cards Don't Count	GoodRx and similar cards bypass insurance entirely — purchases made through them do not count toward deductibles or out-of-pocket maximums.
Front-Loading Saves Real Money	Filling high-cost prescriptions early in the plan year accelerates progress toward the out-of-pocket maximum, which can save specialty drug users thousands annually.
Review Data Between Renewals	Employers who consistently spend less on pharmacy review claims data throughout the year — not just at renewal.

How Drug Coverage Works — and Why the Design Decisions Are Financial Ones

Prescription drug coverage is not a soft benefit. It is a cost-management instrument. The component of an employee health plan that determines which medications are covered, at what cost, and under what conditions directly shapes medication adherence, downstream medical spending, and workforce stability. Cost-related medication rationing affects roughly 10% of Medicaid-enrolled adults and 8% of privately insured adults, compared to 17% of the uninsured. That gap is a coverage design effect, not a population effect.

Medication nonadherence is a cost problem. When employees skip or ration prescriptions because of high out-of-pocket costs, uncontrolled chronic conditions escalate into emergency room visits, hospitalizations, and short-term disability claims. Those events cost employers far more than a well-designed formulary ever would.

The Medicare evidence is instructive. After the Inflation Reduction Act took effect, cost-related nonadherence dropped 4.9 percentage points overall among Medicare beneficiaries. For those managing two or more chronic conditions, the drop was 7.8 percentage points. That is not a marginal improvement. It is a structural shift driven entirely by reducing financial barriers to medication access.

The same logic applies to employer-sponsored plans. Restrictive formularies and high copays push employees to skip doses or abandon therapy, which raises total medical costs for chronic disease populations. HR leaders who treat drug coverage as a cost center rather than a cost-management tool consistently underestimate this effect.

The downstream numbers are concrete:

Employees with uncontrolled diabetes generate higher inpatient claims than those with consistent medication access.
Asthma patients who ration inhalers due to cost are more likely to use urgent care and emergency services.
Specialty drug users who hit cost walls mid-year often abandon therapy entirely, which accelerates disease progression and long-term plan costs.

When reviewing your plan's pharmacy data, look specifically at 30-day refill rates for maintenance medications. Low refill rates on diabetes, hypertension, or asthma drugs are an early signal that cost barriers are building toward a larger claims event.

What Are the Key Design Features of Effective Drug Coverage?

Formulary structure is the single most consequential design decision in a prescription drug plan. A formulary is the plan's approved drug list, organized into tiers that determine cost-sharing at each level. Tier 1 typically covers generic drugs at the lowest copay. Tier 2 covers preferred brand drugs. Tier 3 and above cover non-preferred brands and specialty medications at the highest cost-sharing levels.

Many plans exempt Tier 1 generic drugs from deductibles, applying flat copays from the first fill. Generic copays typically run $10–$20 per fill. That design choice reduces employee cost burden immediately and encourages generic substitution, which lowers plan spending without reducing clinical quality.

Deductible structure matters as much as the formulary itself. In 2026, Medicare Part D sets its deductible cap at $615 and its maximum out-of-pocket at $2,100, with the catastrophic phase costing beneficiaries nothing. Employer plans vary widely, but the principle holds: the higher the deductible, the more employees pay before coverage activates, and the more likely they are to ration medications early in the plan year.

Generic deductible	Applied	Exempt, flat copay
Brand drug copay	$50–$80	$30–$50
Out-of-pocket max	$5,000+	$2,000–$3,500
Prior authorization	Broad use	Limited to specialty
90-day supply option	Not available	Available, lower cost
Home delivery	Not offered	Offered, discounted

Prior authorization adds administrative friction that delays care. Plans that apply it broadly — beyond specialty drugs — create barriers that disproportionately affect employees with complex conditions. Coverage exceptions and appeals processes exist, but they require employee initiative that most people do not take without guidance.

Negotiate with your carrier or PBM to limit prior authorization requirements to Tier 3 and specialty drugs only. Broad prior authorization on Tier 2 drugs generates administrative cost and employee frustration without meaningful savings.

The Benefits of Prescription Insurance Depend on Who Needs Drug Coverage — and How the Plan Is Built Around Them

The low-premium, high-copay plan is the most common cost-shifting strategy in employer benefits. It reduces the employer's monthly contribution but transfers financial risk directly to employees. For healthy employees with minimal medication needs, the tradeoff is manageable. For employees managing hypertension, Type 2 diabetes, or rheumatoid arthritis, it is a direct path to nonadherence and higher downstream claims.

Narrow formularies create a different problem. Employees whose medications are not on the formulary face two choices: pay full price out of network, or switch medications. Neither outcome is clean. Switching requires physician involvement, prior authorization, and sometimes a clinical adjustment period. Full-price purchases outside the plan do not count toward deductibles or out-of-pocket maximums.

Third-party discount cards like GoodRx bypass insurance entirely. Employees often use them unaware that those purchases provide no progress toward their annual deductible or out-of-pocket limit. For an employee on a $1,500 drug deductible, using a discount card for every fill means they never satisfy the deductible and never access the plan's cost-sharing benefits. That is the hidden cost of exploring insurance drug policies without understanding how the pieces connect.

Broad formulary plans improve employee satisfaction and reduce mid-year plan abandonment.
High-deductible plans paired with HSAs work well for healthy, low-utilization employees but create real hardship for chronic condition populations.
Pharmacy costs depend on plan tiers, not pharmacy shelf prices. Employees who do not understand this consistently overpay.
The value of coverage for essential medicines scales with utilization. High-need families benefit far more from plans with lower access barriers than employees with minimal medication use.

Why the Usual Fix Doesn't Work — and What Actually Does

Most employer conversations about pharmacy spend get framed as a premium problem, so the solution becomes a premium solution: raise deductibles, narrow the formulary, shift copays. That approach controls what is visible at renewal and defers what is expensive into the claim year. By Q3, the math has reversed.

The real driver is not premium. It is the gap between what the plan is designed to cover and what the workforce actually needs to cover. A pharmacy benefit built for a healthy, low-utilization population will fail a workforce with a meaningful share of employees managing chronic conditions. The mismatch does not show up on the renewal sheet. It shows up in inpatient claims, ER utilization, and turnover among the employees who depend on the benefit most.

The impact of prescription costs on plan spending is predictable from claims data. The employers who consistently spend less on pharmacy over time are not the ones with the lowest premiums. They are the ones reviewing utilization data between renewals, adjusting plan design to match their actual population's needs rather than a carrier's actuarial average.

Affordable medication access is a financial discipline, not just a design goal. The plan that keeps an employee's blood pressure controlled all year costs less than the plan that sends them to the ER in October.

Strategic Approaches for Employers to Manage Prescription Drug Plans

Benefits leaders who treat pharmacy plan design as a once-a-year renewal exercise miss most of the available savings. The decisions that matter most happen between renewals: employee education, formulary navigation support, and data review.

Audit your claims data by drug tier. Identify which Tier 3 and specialty drugs are driving the most spend. Then determine whether a therapeutic equivalent exists on Tier 1 or Tier 2. A single specialty drug switch can reduce annual plan costs by tens of thousands of dollars.
Educate employees on formulary navigation. Employees can contact their physicians to request a formulary-covered alternative or submit a coverage exception request. Most do not know this option exists. A one-page guide distributed at open enrollment can change that.
Encourage front-loading for high-cost drug users. Front-loading expensive prescriptions early in the plan year accelerates progress toward the out-of-pocket maximum. Once an employee reaches that cap, all subsequent fills are cost-free. For specialty drug users, this strategy can save thousands annually.
Offer 90-day supply and home delivery options. These reduce per-unit drug costs and improve refill consistency. Consistent refills mean better adherence. Better adherence means fewer acute events.
Work with a pharmacy benefit consultant. Plan design decisions made without claims-level data consistently leave money on the table. A consulting partner with access to cost-saving benefits strategies can identify formulary gaps, PBM contract inefficiencies, and employee education opportunities that internal HR teams rarely have bandwidth to pursue.

If your workforce includes a meaningful share of employees managing chronic conditions, model the financial impact of lowering Tier 2 copays by $10. The reduction in ER and inpatient claims from improved adherence often exceeds the premium cost of the change.

What Watching Employers Underinvest in Drug Coverage Teaches You

Most employers I work with do not set out to design a bad pharmacy benefit. They set out to control costs, and they reach for the most visible lever: the premium. They reduce the employer contribution, shift to a high-deductible structure, and narrow the formulary. On paper, the plan year looks cheaper. In practice, the claims catch up by Q3.

The pattern I see repeatedly in nonprofits and care-based organizations is a workforce with a meaningful share of employees managing chronic conditions paired with a pharmacy benefit designed for a healthy, low-utilization population. The mismatch is expensive. It produces medication rationing, avoidable hospitalizations, and turnover among the employees who need benefits most.

The fix is not always spending more. Sometimes it is spending differently. Exempting generics from the deductible costs very little but changes employee behavior immediately. Communicating the out-of-pocket maximum strategy to specialty drug users costs nothing but can save those employees thousands. Understanding employee cost sharing at the plan design level — not just the premium level — is where real savings live.

The employers who get this right treat pharmacy benefits as a clinical and financial tool simultaneously. They review claims data quarterly, communicate formulary changes proactively, and partner with consultants who can translate PBM contract language into actual cost implications. That discipline is available to any organization willing to look at the data.

— Jacob

Work With a Benefits Advisor Who Understands Your Sector

Thrive Benefits Group works with employers across the Southeast — particularly nonprofits and care-based organizations — to build pharmacy benefit structures that reduce costs without reducing access, starting with your claims data. Schedule a conversation to talk through your specific situation.

Schedule a Consultation

How TBG Helps Employers Manage Prescription Drug Costs

TBG's consulting approach identifies formulary inefficiencies, PBM contract gaps, and employee education opportunities that most HR teams do not have time to find on their own. The Thrivebg Cornerstone platform gives employers a centralized view of their benefits performance, including pharmacy spend, so decisions are grounded in actual utilization data rather than carrier estimates. If your current drug benefit is costing more than it should, the starting point is a conversation about what your claims data actually shows.

Frequently Asked Questions

What is the role of prescription drug coverage in employee benefits?

Prescription drug coverage determines which medications employees can access, at what cost, and under what conditions. It directly influences medication adherence, chronic disease management, and total healthcare spending for the plan.

How does formulary design affect employee medication adherence?

Plans with restrictive formularies and high copays cause employees to skip or ration medications, which raises downstream medical costs. Exempting generics from deductibles and limiting prior authorization to specialty drugs improves adherence.

Do third-party discount cards count toward my deductible?

No. Purchases made through discount cards like GoodRx bypass insurance entirely and do not count toward annual deductibles or out-of-pocket maximums, which can increase total yearly drug expenses for employees on high-deductible plans.

What is the best strategy for employees with high-cost specialty drugs?

Front-loading specialty drug fills early in the plan year accelerates progress toward the out-of-pocket maximum. Once that cap is reached, all subsequent fills are cost-free, which produces meaningful savings for chronic and specialty drug users.

How can HR professionals reduce prescription drug costs without cutting coverage?

Auditing claims by drug tier, encouraging generic substitution, educating employees on formulary navigation and coverage exceptions, and offering 90-day supply options are the highest-impact steps that do not require reducing benefit levels.